# Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

> **NCT01525953** · — · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 110 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Chemotherapy
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01525953
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525953, "Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01525953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*